Products Categories
CAS No.: | 1977-10-2 |
---|---|
Name: | loxapine |
Article Data: | 8 |
Molecular Structure: | |
Formula: | C18H18 Cl N3 O |
Molecular Weight: | 327.813 |
Synonyms: | 2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine;2-Chloro-11-(4-methylpiperazino)dibenz[b,f][1,4]oxazepine; CL 62362;Cloxazepine; HF 3170; LW 3170; Loxapin; Loxapine; Loxitane IM; Oxilapine; S805; SUM 3170 |
Density: | 1.31g/cm3 |
Melting Point: | 109-110° |
Boiling Point: | 458.6°Cat760mmHg |
Flash Point: | 231.1°C |
Safety: | Poison by ingestion, intraperitoneal, subcutaneous, and intravenous routes. Experimental teratogenic and reproductive effects. A tranquilizer. Many dibenz-azepine compounds have central nervous system effects. When heated to decomposition it emits very toxic fumes of Cl− and NOx. |
PSA: | 28.07000 |
LogP: | 3.08280 |
Product Name: Dibenzacepin (CAS NO.1977-10-2)
Molecular Formula: C18H18ClN3O
Molecular Weight: 327.84g/mol
Mol File: 1977-10-2.mol
Einecs: 217-835-3
Boiling point: 458.6 °C at 760 mmHg
Flash Point: 231.1 °C
Density: 1.31 g/cm3
Surface Tension: 48.5 dyne/cm
Enthalpy of Vaporization: 71.89 kJ/mol
Vapour Pressure: 1.36E-08 mmHg at 25°C
XLogP3-AA: 3.1
H-Bond Donor: 0
H-Bond Acceptor: 4
Structure Descriptors of Dibenzacepin (CAS NO.1977-10-2):
IUPAC Name: 8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,5]benzoxazepine
Canonical SMILES: CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
InChI: InChI=1S/C18H18ClN3O/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18/h2-7,12H,8-11H2,1H3
InChIKey: XJGVXQDUIWGIRW-UHFFFAOYSA-N
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
cat | LD | subcutaneous | > 50mg/kg (50mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: ATAXIA KIDNEY, URETER, AND BLADDER: OTHER CHANGES | Oyo Yakuri. Pharmacometrics. Vol. 4, Pg. 131, 1970. |
dog | LD | subcutaneous | > 50mg/kg (50mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD GASTROINTESTINAL: NAUSEA OR VOMITING | Oyo Yakuri. Pharmacometrics. Vol. 4, Pg. 131, 1970. |
guinea pig | LDLo | subcutaneous | 100mg/kg (100mg/kg) | SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE BEHAVIORAL: REGIDITY BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) | Oyo Yakuri. Pharmacometrics. Vol. 4, Pg. 131, 1970. |
mouse | LD50 | intraperitoneal | 27mg/kg (27mg/kg) | "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 79, 1972. | |
mouse | LD50 | intravenous | 22mg/kg (22mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: TREMOR BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Oyo Yakuri. Pharmacometrics. Vol. 4, Pg. 293, 1970. |
mouse | LD50 | oral | 40mg/kg (40mg/kg) | "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 79, 1972. | |
mouse | LD50 | subcutaneous | 53mg/kg (53mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: TREMOR | Oyo Yakuri. Pharmacometrics. Vol. 4, Pg. 293, 1970. |
rabbit | LDLo | subcutaneous | 50mg/kg (50mg/kg) | SENSE ORGANS AND SPECIAL SENSES: MIOSIS (PUPILLARY CONSTRICTION): EYE SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE | Oyo Yakuri. Pharmacometrics. Vol. 4, Pg. 131, 1970. |
rat | LD50 | intraperitoneal | 35mg/kg (35mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: TREMOR BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Oyo Yakuri. Pharmacometrics. Vol. 4, Pg. 293, 1970. |
rat | LD50 | intravenous | 18mg/kg (18mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: TREMOR BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Oyo Yakuri. Pharmacometrics. Vol. 4, Pg. 293, 1970. |
rat | LD50 | oral | 151mg/kg (151mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: TREMOR BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Oyo Yakuri. Pharmacometrics. Vol. 4, Pg. 293, 1970. |
rat | LD50 | subcutaneous | 350mg/kg (350mg/kg) | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: TREMOR BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Oyo Yakuri. Pharmacometrics. Vol. 4, Pg. 293, 1970. |
Poison by ingestion, intraperitoneal, subcutaneous, and intravenous routes. Experimental teratogenic and reproductive effects. A tranquilizer. Many dibenz-azepine compounds have central nervous system effects. When heated to decomposition it emits very toxic fumes of Cl− and NOx.
Dibenzacepin ,its CAS NO. is 1977-10-2,the synonyms is 2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine ; 2-Chloro-11-(4-methylpiperazino)dibenzo(b,f)(1,4)oxazepine ; BRN 0626753 ; CL 62362 ; Cloxazepine ; Dibenz(b,f)(1,4)oxazepine, 2-chloro-11-(4-methyl-1-piperazinyl)- ; EINECS 217-835-3 ; HF 3170 ; HSDB 3111 ; Hydrofluoride 3170 ; LW 3170 ; Lossapina ; Oxilapine ; S 805 ; SUM 3170 ; UNII-LER583670J .